• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Imaging the adrenal medulla with an I-131-labeled antiadrenergic agent.

作者信息

Wieland D M, Swanson D P, Brown L E, Beierwaltes W H

出版信息

J Nucl Med. 1979 Feb;20(2):155-8.

PMID:430189
Abstract

Tissue distributions of four antiadrenergic agents labeled with iodine-125 have been determined in dogs. [125I] ortho-iodobenzldimethyl-2-hydroxyethyl ammonium and [125I] ortho-iodobenzyldimethylethyl ammonium show highly selective uptake in the adrenal medulla. Studies of molecular structure-distribution indicate that both the nature of the cationic head and the ring position of the iodine atom greatly influence adrenal specificity. Distinct images of dogs' adrenal medulla have been obtained 4 days after i.v. injection of 1.5 mCi of [131I] ortho-iodobenzyldimethyl-2-hydroxyethyl ammonium.

摘要

相似文献

1
Imaging the adrenal medulla with an I-131-labeled antiadrenergic agent.
J Nucl Med. 1979 Feb;20(2):155-8.
2
Radiolabeled adrenergi neuron-blocking agents: adrenomedullary imaging with [131I]iodobenzylguanidine.放射性标记的肾上腺素能神经元阻断剂:用[131I]碘苄胍进行肾上腺髓质显像。
J Nucl Med. 1980 Apr;21(4):349-53.
3
Adrenal medulla imaging agents: a structure-distribution relationship study of radiolabeled aralkylguanidines.
J Med Chem. 1984 Feb;27(2):149-55. doi: 10.1021/jm00368a008.
4
Imaging the primate adrenal medulla with [123I] and [131I] meta-iodobenzylguanidine: concise communication.用[123I]和[131I]间碘苄胍对灵长类动物肾上腺髓质进行成像:简要通讯
J Nucl Med. 1981 Apr;22(4):358-64.
5
Evaluation of a new adrenomedullary imaging agent: 131I-meta-iodobenzylguanidine (131I-MIBG). I: Experimental studies on animals.
Rays. 1985 May-Aug;10(2):117-24.
6
Meta-iodobenzylguanidine adrenal medulla localization: autoradiographic and pharmacologic studies.间碘苄胍肾上腺髓质定位:放射自显影和药理学研究
Eur J Nucl Med. 1984;9(6):278-81. doi: 10.1007/BF00803250.
7
A radioiodinated bretylium analog as a potential agent for scanning the adrenal medulla.
J Nucl Med. 1977 Jan;18(1):87-9.
8
[Iodo carboxamidino-1 phenyl-4 piperazine, a new adrenomedullary imaging agent: comparison with metaiodobenzylguanidine].
Int J Nucl Med Biol. 1986;12(6):495-6.
9
Concentration of dopamine analogs in the adrenal medulla.
J Nucl Med. 1975 Dec;16(12):1147-51.
10
Detection of norepinephrine distribution in rats with adrenal medulla autotransplants using 125I-meta-iodobenzyl guanidine.
Nucl Med Commun. 1994 Sep;15(9):752-7. doi: 10.1097/00006231-199409000-00015.

引用本文的文献

1
Emerging Trends in Neuroblastoma Diagnosis, Therapeutics, and Research.神经母细胞瘤诊断、治疗与研究的新趋势
Mol Neurobiol. 2025 May;62(5):6423-6466. doi: 10.1007/s12035-024-04680-w. Epub 2025 Jan 13.
2
Iodine-123 Metaiodobenzylguanidine (I-123 MIBG) in Clinical Applications: A Comprehensive Review.碘-123间碘苄胍(I-123 MIBG)的临床应用:综述
Pharmaceuticals (Basel). 2024 Nov 21;17(12):1563. doi: 10.3390/ph17121563.
3
Safety and efficacy of multiple-dose versus single-dose MIBG therapy in patients with refractory pheochromocytoma and paraganglioma: a single-center retrospective analysis.
多剂量与单次剂量 MIBG 治疗难治性嗜铬细胞瘤和副神经节瘤患者的安全性和疗效:单中心回顾性分析。
Ann Nucl Med. 2024 Jul;38(7):553-562. doi: 10.1007/s12149-024-01928-2. Epub 2024 Apr 24.
4
Hybrid Molecules of Benzylguanidine and the Alkylating Group of Melphalan: Synthesis and Effects on Neuroblastoma Cells.苄基胍与美法仑烷化基团的杂合分子:合成及其对神经母细胞瘤细胞的作用
J Clin Med. 2023 Jul 3;12(13):4469. doi: 10.3390/jcm12134469.
5
Clinical Advances and Perspectives in Targeted Radionuclide Therapy.靶向放射性核素治疗的临床进展与展望
Pharmaceutics. 2023 Jun 14;15(6):1733. doi: 10.3390/pharmaceutics15061733.
6
Management of pheochromocytomas and paragangliomas: Review of current diagnosis and treatment options.处理嗜铬细胞瘤和副神经节瘤:当前诊断和治疗选择的综述。
Cancer Med. 2023 Jul;12(13):13942-13957. doi: 10.1002/cam4.6010. Epub 2023 May 5.
7
MIBG Therapy for Neuroblastoma: Precision Achieved With Dosimetry, and Concern for False Responders.间碘苄胍治疗神经母细胞瘤:剂量测定实现精准治疗,并关注假反应者。
Front Med (Lausanne). 2020 May 28;7:173. doi: 10.3389/fmed.2020.00173. eCollection 2020.
8
Prediction of ong-term ardiac vents by 123I-meta-odobenzylguanidine maging after acute yocardial nfarction and eperfusion herapy.急性心肌梗死后再灌注治疗后用123I-间碘苄胍显像预测长期心脏事件
Asia Ocean J Nucl Med Biol. 2019 Spring;7(2):121-128. doi: 10.22038/AOJNMB.2019.33991.1236.
9
Targeted Radionuclide Therapy for Patients with Metastatic Pheochromocytoma and Paraganglioma: From Low-Specific-Activity to High-Specific-Activity Iodine-131 Metaiodobenzylguanidine.转移性嗜铬细胞瘤和副神经节瘤患者的靶向放射性核素治疗:从低比活度到高比活度碘-131间碘苄胍
Cancers (Basel). 2019 Jul 20;11(7):1018. doi: 10.3390/cancers11071018.
10
A phase I clinical trial for [I]meta-iodobenzylguanidine therapy in patients with refractory pheochromocytoma and paraganglioma.一项关于[I]meta-碘苄胍治疗耐药性嗜铬细胞瘤和副神经节瘤患者的 I 期临床试验。
Sci Rep. 2019 May 20;9(1):7625. doi: 10.1038/s41598-019-43880-6.